A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -47.29% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -67.60%. Over the past 30 days, the price of CCCC has leaped by -5.47%. And in the last five days, it has fallen by -6.89%.
The stock of C4 Therapeutics Inc. (CCCC) is currently priced at $3.11. In the last session, the stock climbed significantly, topping out at $3.27 after opening at $3.27. The day’s lowest price was $3.055 before the stock closed at $3.27.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
C4 Therapeutics Inc. ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $13.23 on 08/08/22, while the lowest value for the same period was recorded at $2.85 on 04/28/23.
52-week price history of CCCC Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. C4 Therapeutics Inc.’s current trading price is -76.50% away from its 52-week high, while its distance from the 52-week low is 9.12%. The stock’s price range during this period has varied between$2.85 and $13.23. The C4 Therapeutics Inc.’s shares, which operate in the Healthcare, saw a trading volume of around 0.57 million for the day, a figure considerably higher than their average daily volume of 0.56 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
C4 Therapeutics Inc. (CCCC) has experienced a quarterly decline of -45.91% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 148.38M and boasts a workforce of 146 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.94, with a change in price of -2.31. Similarly, C4 Therapeutics Inc. recorded 548,784 in trading volume during the last 100 days, posting a change of -42.62%.
CCCC’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CCCC stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.03.
CCCC Stock Stochastic Average
C4 Therapeutics Inc.’s raw stochastic average for the past 50 days is presently 14.86%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 37.14%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 48.10% and 46.35%, respectively.
